
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **FABP3 (Fatty Acid Binding Protein 3):** Involved in fatty acid uptake, transport, and metabolism.<br>- **DHRS2 (Dehydrogenase/Reductase 2):** Participates in retinoid metabolism and may play a role in cellular differentiation.<br>- **STC2 (Stanniocalcin 2):** Involved in calcium and phosphate homeostasis.<br>- **RAMP1 (Receptor Activity Modifying Protein 1):** Modulates the activity of G protein-coupled receptors.<br>- **MGP (Matrix Gla Protein):** Inhibits vascular calcification.<br>- **COX6C (Cytochrome c Oxidase Subunit 6C):** Part of the electron transport chain in mitochondria.<br>- **KRT19 (Keratin 19):** Structural protein in epithelial cells.<br>- **KRT18 (Keratin 18):** Intermediate filament protein in epithelial cells.<br>- **KRT8 (Keratin 8):** Intermediate filament protein in epithelial cells.<br>- **GATA3 (GATA Binding Protein 3):** Transcription factor involved in cell differentiation, particularly in the immune system and epithelial cells.<br>- **ESR1 (Estrogen Receptor 1):** Nuclear hormone receptor for estrogen, involved in transcriptional regulation.<br>- **XBP1 (X-Box Binding Protein 1):** Transcription factor involved in the unfolded protein response.<br><br>### Step 2: List the Key Cell Type Markers<br>- **SCGB2A2 (Secretoglobin Family 2A Member 2):** Also known as Mammaglobin, a marker for breast epithelial cells.<br>- **ANKRD30A (Ankyrin Repeat Domain 30A):** Known as NY-BR-1, a breast cancer antigen.<br>- **SUSD3 (Sushi Domain Containing 3):** Expressed in breast tissue.<br>- **CLDN3 (Claudin 3):** Tight junction protein, often expressed in epithelial cells.<br>- **ELF3 (E74 Like ETS Transcription Factor 3):** Involved in epithelial cell differentiation.<br>- **AGR3 (Anterior Gradient 3):** Associated with breast tissue and cancer.<br>- **CD24:** Cell surface protein, often used as a marker for epithelial and cancer stem cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer and epithelial cell markers, we can confirm that many of these markers are associated with breast epithelial cells and breast cancer.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of markers like SCGB2A2, KRT19, KRT18, KRT8, GATA3, ESR1, and ELF3, the most probable general cell type is **breast epithelial cells**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells:** High expression of SCGB2A2, ESR1, and GATA3 suggests luminal epithelial cells, which are common in breast tissue.<br>2. **Luminal Progenitor Cells:** Expression of KRT19 and KRT18, along with ESR1, can also indicate luminal progenitor cells.<br>3. **Basal/Myoepithelial Cells:** Although less likely due to the lack of specific basal markers, the presence of some keratins could suggest a minor population of basal cells.<br><br>The most likely subtype based on the markers is **Luminal Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of breast epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the high expression of markers such as SCGB2A2, ESR1, and GATA3, which are characteristic of luminal epithelial cells in breast tissue.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers SCGB2A2, KRT19, KRT18, KRT8, GATA3, ESR1, and ELF3 are all associated with breast epithelial cells, particularly luminal epithelial cells, which aligns with the annotation.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation considers the possibility of mixed cell types, such as luminal progenitor cells and basal/myoepithelial cells, but concludes that luminal epithelial cells are the most likely subtype based on the marker expression.<br>   - The presence of multiple keratins and other markers supports the primary annotation of luminal epithelial cells, with a minor possibility of other subtypes, which is appropriately flagged for further investigation if needed.<br><br>Overall, the annotation is well-supported by the marker list and the analysis provided.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">breast epithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>luminal epithelial cells</li><li>luminal progenitor cells</li><li>basal/myoepithelial cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the single-cell data, particularly in the context of breast cancer. The analysis correctly identifies the main cell type as breast epithelial cells, with a focus on luminal epithelial cells, which is consistent with the marker list. The use of key markers such as SCGB2A2, ESR1, and GATA3, which are highly indicative of luminal epithelial cells, supports this conclusion. The annotation also considers the possibility of other subtypes, such as luminal progenitor cells and basal/myoepithelial cells, which shows a balanced approach to the data.<br><br>The analysis effectively uses a variety of markers, including both functional and cell type-specific markers, to draw its conclusions. This balanced consideration of multiple markers rather than over-focusing on a specific one is a strength of the annotation. The annotation also appropriately references known databases and literature, which adds credibility to the conclusions drawn.<br><br>However, there are a few areas where the annotation could be improved. While the analysis considers the possibility of mixed cell types, it does not provide a detailed exploration of the potential for mixed populations within the dataset. Additionally, the rank of the markers is not explicitly considered in the analysis, which could provide further insight into the relative importance of each marker in determining the cell type.<br><br>Overall, the annotation is scientifically accurate and provides a comprehensive view of the cell types present in the dataset. There are no obvious misclassifications or oversights, and the analysis captures the general picture of the cell populations effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    